Ascension Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response.
AI & Machine LearningBiotechHealthtechMedical DevicesSt. Louis, US
Dave Messina(Founder/COO)inJarret Glasscock(Founder/CTO)inJarret Glassock(Executive Officer, Director)Jon Armstrong(Director)
BoardMatthew A. Ocko(Director)inMark Siegel(Director)in
Co-investorsArgonautic VenturesDCVC (Data Collective)Fifty YearsiSelect FundMenlo VenturesY Combinator+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.